logo-loader

Concepta chairman sees significant opportunity for its myLotus fertility product

Published: 06:25 17 May 2019 EDT

Concepta PLC (LON:CPTA) chairman Matthew Walls spoke to Proactive London's Andrew Scott following the release of the firm's 2018 results and news of some early success with its fertility product.

The myLotus product for couples in the early stages of trying to conceive went on sale last year and a supply agreement was struck with Boots in the UK in March.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

2 hours, 6 minutes ago